Proteomics Analysis for Recognition of Acute Cellular Rejection After Lung Transplantation
The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2008 by Hannover Medical School.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Hannover Medical School
Information provided by:
Hannover Medical School
ClinicalTrials.gov Identifier:
NCT00558597
First received: November 14, 2007
Last updated: July 19, 2011
Last verified: September 2008
| Tracking Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| First Received Date ICMJE | November 14, 2007 | ||||||||
| Last Updated Date | July 19, 2011 | ||||||||
| Start Date ICMJE | March 2008 | ||||||||
| Primary Completion Date | Not Provided | ||||||||
| Current Primary Outcome Measures ICMJE | Not Provided | ||||||||
| Original Primary Outcome Measures ICMJE | Not Provided | ||||||||
| Change History | Complete list of historical versions of study NCT00558597 on ClinicalTrials.gov Archive Site | ||||||||
| Current Secondary Outcome Measures ICMJE | Not Provided | ||||||||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||||||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||||||
| Descriptive Information | |||||||||
| Brief Title ICMJE | Proteomics Analysis for Recognition of Acute Cellular Rejection After Lung Transplantation | ||||||||
| Official Title ICMJE | Proteomics Analysis for Recognition of Acute Cellular Rejection After Lung Transplantation | ||||||||
| Brief Summary | In patients with acute rejection after lung transplantation the peptide profile in broncho-alveolar lavage (BAL) and urine should be compared in order to identify a paradigm that allows an non-invasive rejection therapy. |
||||||||
| Detailed Description | Goal of the study is the establishment of biomarkers for early diagnosis of acute rejection, followed by a late validation of the paradigm with prospectively collected samples, which will be examined blinded. |
||||||||
| Study Type ICMJE | Observational | ||||||||
| Study Design ICMJE | Observational Model: Case Control Time Perspective: Prospective |
||||||||
| Target Follow-Up Duration | Not Provided | ||||||||
| Biospecimen | Retention: Samples Without DNA Description: BAL (broncho alveolar lavage) urine |
||||||||
| Sampling Method | Probability Sample | ||||||||
| Study Population | patients after lung transplantation |
||||||||
| Condition ICMJE |
|
||||||||
| Intervention ICMJE | Not Provided | ||||||||
| Study Group/Cohort (s) |
|
||||||||
| Publications * | Not Provided | ||||||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||||
| Recruitment Information | |||||||||
| Recruitment Status ICMJE | Recruiting | ||||||||
| Estimated Enrollment ICMJE | 60 | ||||||||
| Estimated Completion Date | December 2011 | ||||||||
| Primary Completion Date | Not Provided | ||||||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||||||
| Gender | Both | ||||||||
| Ages | 18 Years to 70 Years | ||||||||
| Accepts Healthy Volunteers | No | ||||||||
| Contacts ICMJE |
|
||||||||
| Location Countries ICMJE | Germany | ||||||||
| Administrative Information | |||||||||
| NCT Number ICMJE | NCT00558597 | ||||||||
| Other Study ID Numbers ICMJE | 154 | ||||||||
| Has Data Monitoring Committee | No | ||||||||
| Responsible Party | Hannover Medical School, Medical School | ||||||||
| Study Sponsor ICMJE | Hannover Medical School | ||||||||
| Collaborators ICMJE | Not Provided | ||||||||
| Investigators ICMJE |
|
||||||||
| Information Provided By | Hannover Medical School | ||||||||
| Verification Date | September 2008 | ||||||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||||||